Flow cytometry revealed that 85.1% of CD33+ cells were confined to the CD33+CD11b+LIN− HLA-DR−/low type in ovarian tumor samples, and these cells expressed high levels of Arginase 1 regardless of HLA-DR expression (Supplementary Fig. 6). Here, CD33 is linked to ovarian neoplasm.